Wockhardt USA LLC

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK 771

First Posted Date
2022-12-07
Last Posted Date
2022-12-07
Lead Sponsor
Wockhardt
Target Recruit Count
36
Registration Number
NCT05640531
Locations
๐Ÿ‡บ๐Ÿ‡ธ

PPD Phase I Clinic, 7551 Metro Center Drive, Suite 200, Austin, Texas, United States

Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

First Posted Date
2021-07-28
Last Posted Date
2024-06-27
Lead Sponsor
Wockhardt
Target Recruit Count
528
Registration Number
NCT04979806
Locations
๐Ÿ‡ฒ๐Ÿ‡ฝ

Guadalajara, Guadalajara, Mexico

๐Ÿ‡ฎ๐Ÿ‡ณ

Chandigarh, Chandigarh, Punjab, India

๐Ÿ‡บ๐Ÿ‡ธ

Chula Vista, Chula Vista, California, United States

and more 37 locations

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Oral WCK 2349

Phase 1
Completed
Conditions
Pharmacokinetics
Interventions
Drug: WCK 2349 Oral
Other: Placebo Oral
First Posted Date
2021-05-05
Last Posted Date
2022-12-01
Lead Sponsor
Wockhardt
Target Recruit Count
36
Registration Number
NCT04874324

Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous Nafithromycin

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Nafithromycin
Other: Placebo
First Posted Date
2019-06-11
Last Posted Date
2019-10-02
Lead Sponsor
Wockhardt
Target Recruit Count
10
Registration Number
NCT03981887
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Spaulding Clinical Research, West Bend, Wisconsin, United States

Evaluate The Safety, Tolerability and Pharmacokinetics Of Multiple Ascending Oral Doses Of WCK 4873 In Healthy Adult Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: WCK 4873
Drug: Placebo Oral Tablet
First Posted Date
2019-06-07
Last Posted Date
2019-06-11
Lead Sponsor
Wockhardt
Target Recruit Count
30
Registration Number
NCT03979859

The Safety, Tolerability And Pharmacokinetics Of Single Ascending Doses And The Effect Of Food On Oral WCK 4873 In Healthy Adult Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: WCK 4873
Drug: Placebo Oral Tablet
First Posted Date
2019-04-25
Last Posted Date
2019-04-25
Lead Sponsor
Wockhardt
Target Recruit Count
67
Registration Number
NCT03926962

Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

First Posted Date
2018-08-14
Last Posted Date
2023-07-17
Lead Sponsor
Wockhardt
Target Recruit Count
1004
Registration Number
NCT03630081

Plasma and Intrapulmonary Concentrations Study of WCK 5222

Phase 1
Completed
Conditions
PHA1A
Interventions
Drug: FEP-ZID
First Posted Date
2018-08-14
Last Posted Date
2018-08-14
Lead Sponsor
Wockhardt
Target Recruit Count
36
Registration Number
NCT03630094
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Pulmonary Associates, Phoenix, Arizona, United States

To Investigate the Multiple Dose Safety, Tolerability and Pharmacokinetics of WCK 4282 (FEP-TAZ)

First Posted Date
2018-08-09
Last Posted Date
2018-08-10
Lead Sponsor
Wockhardt
Target Recruit Count
20
Registration Number
NCT03622008
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Spaulding Clinical Research, West Bend, Wisconsin, United States

Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers

First Posted Date
2018-06-13
Last Posted Date
2018-06-13
Lead Sponsor
Wockhardt
Target Recruit Count
60
Registration Number
NCT03554304
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Spaulding Clinical Research, West Bend, Wisconsin, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy